Covered recipient · General Payments record
MATTHEW CHURCHILL
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,115.93
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $491.22 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $168.73 | 3 |
| ABBVIE INC. | $140.13 | 13 |
| PFIZER INC. | $43.36 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.50 | 1 |
| ARGENX US, INC. | $25.36 | 1 |
| Life Molecular Imaging Ltd | $23.82 | 1 |
| UCB, Inc. | $22.84 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.50 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.85 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473545 | CMS |
| ABBVIE INC. | $3.74 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473547 | CMS |
| ABBVIE INC. | $19.14 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473549 | CMS |
| ABBVIE INC. | $8.70 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473551 | CMS |
| ABBVIE INC. | $6.04 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473553 | CMS |
| ABBVIE INC. | $33.29 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473555 | CMS |
| ABBVIE INC. | $9.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473557 | CMS |
| ABBVIE INC. | $9.85 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473559 | CMS |
| ABBVIE INC. | $7.05 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473561 | CMS |
| ABBVIE INC. | $1.56 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473563 | CMS |
| ABBVIE INC. | $16.61 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473565 | CMS |
| ABBVIE INC. | $6.93 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473567 | CMS |
| ABBVIE INC. | $7.71 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103473569 | CMS |
| ARGENX US, INC. | $25.36 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142107927 | CMS |
| Life Molecular Imaging Ltd | $23.82 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154809052 | CMS |
| Lilly USA, LLC | $24.56 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135185369 | CMS |
| Lilly USA, LLC | $25.37 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135170592 | CMS |
| Lilly USA, LLC | $118.80 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135170594 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118876478 | CMS |
| PFIZER INC. | $25.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131122884 | CMS |
| PFIZER INC. | $18.10 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132101583 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137513837 | CMS |
| UCB, Inc. | $22.84 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143163841 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $16.50 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105910906 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.